Skip to main content

Pharmaceuticals

Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.

Pharmaceuticals

23 results for Pharmaceuticals
CLEAR ALL
Actylis
Excipient for use in pharmaceutical applications.
Actylis
Solvent/ Co-solvent developed exclusively for use in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20190000639
Actylis
Solvent/co-solvent for pharmaceutical injectable formulations. It has a strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing.Benefits:
  • It maintains low level of endotoxins with the bioburden limits- BET/MLT
  • Controlled metallic impurities
  •  Developed for…
Actylis
Antioxidant for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient for pharmaceutical applications such as solid and semi-solid dosage forms.Benefits:
  • DMF filed excipient - CDE # F20200000188
  • All peak positions are within 5cm-1cm of those determined for 3-tert-Butyl-4-hydroxyanisole standard
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
Excipient specially developed for solid and semi-solid dosage forms. It is an antioxidant and reducing agent used in injectable formulations.Benefits:
  • Maintains low level of endotoxins with the bioburden limits (BET/MLT etc)
  • DMF Filed - CDE # F20200000189
Actylis
pH adjustment and coating excipient for use in various drug formulations that are intended for NDA and ANDA filing.Benefits:
  • China DMF No. : CDE # F20200000397
  • Complies with USP-NF, JP, Ch.P specifications
  • It is GMP and EXCiPACT certified
Actylis
pH adjustment and coating excipient for use in various drug formulations that are intended for NDA and ANDA filing.Benefits:
  • DMF No. : USDMF # 24710, CDE # F20180001596
  • Available as clear, colorless liquid
  • It is GMP and EXCiPACT certified
Actylis
Plasticizer and coating excipient for several oral solid dosage formulations. It is used in various drug formulations that are intended for NDA and ANDA filing.Benefits:
  • Shows strong control on all possible impurities along with ICH Q3D compliance for R&D to commercial manufacturing
  • China DMF No. : CDE # F20200000446
Actylis
Excipient designed for pharmaceutical applications.Benefits:
  • Assay: 99.48 %
  • Meets with CDMF specifications
  • CDE registration no- F20190000136
Actylis
Excipient developed for pharmaceutical applications. It is used as a solvent in oral solid dosage forms. Benefits:
  • Highly pure
  • Complies with USP-NF and Ph Eur specifications
Actylis
Excipient developed for pharmaceutical formulations. It is used in para-effervescent tablets. Benefits:
  • Freely soluble in water
  • Meets with USDMF requirements
Actylis
Excipient developed for pharmaceutical applications. It is used as a preservative and antioxidant in solid and semi-solid dosage formulations.     Benefits:
  • Miscible with alcohol & slightly soluble in water
  • Meets with CDMF requirements
  • Complies with USP-NF specifications
Actylis
Excipient developed for pharmaceutical formulations. Benefits:
  • Purity: 99.92 % (Gas Chromatography)
  • Miscible with ethanol, water and most common solvent
  • Meets with CDMF specifications
Actylis
Excipient developed for pharmaceutical injectable formulations. Benefits:
  • Odorless powder
  • Assay: 99.8%
  • Complies with CDMF and USP specifications